Allogeneic Cell Therapy Market Report 2026
Download Free Sample Buy Now
Allogeneic Cell Therapy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Allogeneic Cell Therapy Market Report 2026

Global Outlook – By Type (Stem Cell Therapies, Non-Stem Cell Therapies ), By Therapeutic Area (Hematological Disorders, Dermatological Disorders), By End User (Hospitals, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Allogeneic Cell Therapy Market Overview

• Allogeneic Cell Therapy market size has reached to $1.2 billion in 2025

• Expected to grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%

• Growth Driver: Allogeneic Cell Therapy Revolutionizing The Treatment Of Chronic Illnesses

• Market Trend: Innovative Cell Processing Platforms Strengthen Market Position Of Allogeneic Cell Therapy Companies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Allogeneic Cell Therapy Market?

Allogeneic cell therapy is a treatment in which cells are harvested from a donor and used to treat a different individual (the recipient). These therapies are designed to replace or repair damaged tissues, modulate immune responses, or treat diseases such as cancer, genetic disorders, and autoimmune conditions.

The main types of allogenic cell therapy are stem cell therapies and non-stem cell therapies. Stem cell therapies are treatments that utilize stem cells to repair, regenerate, or replace damaged tissues or organs to prevent or treat various diseases and conditions. The various therapeutic areas are hematological disorders, dermatological disorders, and other therapeutic areas used by various end users such as hospitals, specialty clinics, and research organizations.

Allogeneic Cell Therapy Market Global Report 2026 Market Report bar graph

What Is The Allogeneic Cell Therapy Market Size and Share 2026?

The allogeneic cell therapy market size has grown rapidly in recent years. It will grow from $1.2 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to limited availability of allogeneic cell therapy products, early-stage clinical trials expansion, increasing hematological disorder prevalence, growing hospital adoption of cell therapies, reliance on donor cell banks.

What Is The Allogeneic Cell Therapy Market Growth Forecast?

The allogeneic cell therapy market size is expected to see rapid growth in the next few years. It will grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to advancements in stem cell and immune cell engineering, expansion of dermatological and other therapeutic applications, increasing investment in cell therapy manufacturing facilities, collaborations between hospitals and biotech firms, adoption of automated cell processing technologies. Major trends in the forecast period include increasing adoption of stem cell therapies, rising focus on t-cell and nk cell therapies, expansion of ipsc-based therapeutic applications, growing demand for personalized cell therapy treatments, enhanced regulatory oversight and safety standards.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Allogeneic Cell Therapy Market Segmentation

1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders

3) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy

2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies

What Is The Driver Of The Allogeneic Cell Therapy Market?

The increasing prevalence of chronic diseases is expected to drive the growth of the allogeneic cell therapy market. Chronic disease is a long-lasting condition that typically requires ongoing medical attention and can limit daily activities or quality of life. The prevalence of chronic disease is due to altered habits, inheritance, and exposure to chemicals, toxins, and pollutants in the air. Allogeneic cell therapy holds significant potential for treating a wide range of chronic diseases by utilizing healthy cells from a donor to repair, replace, or modulate the dysfunctional cells or tissues in the recipient. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based medicine library, the number of people aged 50 and above who suffer from one or more chronic illnesses is expected to increase by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the increased prevalence of chronic diseases drives the growth of the allogeneic cell therapy industry.

Key Players In The Global Allogeneic Cell Therapy Market

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

Global Allogeneic Cell Therapy Market Trends and Insights

Major companies operating in the allogeneic cell therapy market are focusing on developing innovative solutions, such as cell processing platforms, to strengthen their position in the market. Cell processing platforms are systems and technologies used to prepare and manipulate cells for therapeutic applications, encompassing isolation, purification, expansion, modification, and quality control to ensure cells are suitable for clinical use. For instance, in March 2024, Getinge, a Sweden-based healthcare company, partnered with CellRev, a UK-based biotechnology company, to launch Livit ACE, a platform for continuous cell processing (Adherent Cell Expansion). This innovative platform integrates advanced automation and bioprocessing technologies, significantly enhancing the efficiency and scalability of cell production. Its unique features include state-of-the-art cell isolation and purification systems that ensure high cell purity and viability, robust expansion capabilities to produce large quantities of therapeutic cells, sophisticated genetic modification tools for precise cell engineering, and rigorous quality control measures to guarantee the safety and efficacy of the cell products.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Allogeneic Cell Therapy Market?

In February 2024, AstraZeneca, a UK-based pharmaceutical company focused on oncology and rare diseases, acquired Gracell Biotechnologies for an undisclosed amount. With this acquisition, AstraZeneca aims to strengthen its position in oncology and rare diseases by integrating Gracell Biotechnologies' advanced cell therapy capabilities, potentially accelerating the development of innovative treatments for challenging cancers and other serious conditions. Gracell Biotechnologies is a China-based company that offers allogeneic cell therapy.

Regional Outlook

North America was the largest region in the allogeneic cell therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allogeneic Cell Therapy Market?

The allogeneic cell therapy market includes revenues earned by entities through induced pluripotent stem cell therapy, hematopoietic stem cell transplantation, mesenchymal stem cell (MSC) therapy, induced pluripotent stem cell (IPSC) therapy and chimeric antigen receptor T cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Allogeneic Cell Therapy Market Report 2026?

The allogeneic cell therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allogeneic cell therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Allogeneic Cell Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.34 billion
Revenue Forecast In 2035 $1.97 billion
Growth Rate CAGR of 11.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Therapeutic Area, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Allogeneic Cell Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Allogeneic Cell Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Allogeneic Cell Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Allogeneic Cell Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Industry 4.0 And Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Artificial Intelligence And Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Stem Cell Therapies

4.2.2 Rising Focus On T-Cell And Nk Cell Therapies

4.2.3 Expansion Of Ipsc-Based Therapeutic Applications

4.2.4 Growing Demand For Personalized Cell Therapy Treatments

4.2.5 Enhanced Regulatory Oversight And Safety Standards

5. Allogeneic Cell Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Research Organizations

5.4 Biotechnology Companies

5.5 Contract Research Organizations

6. Allogeneic Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Allogeneic Cell Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Allogeneic Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Allogeneic Cell Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Allogeneic Cell Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Allogeneic Cell Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Allogeneic Cell Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Allogeneic Cell Therapy Market Segmentation

9.1. Global Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stem Cell Therapies, Non-Stem Cell Therapies

9.2. Global Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hematological Disorders, Dermatological Disorders

9.3. Global Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics

9.4. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy

9.5. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Non-Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies

10. Allogeneic Cell Therapy Market Regional And Country Analysis

10.1. Global Allogeneic Cell Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Allogeneic Cell Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Allogeneic Cell Therapy Market

11.1. Asia-Pacific Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Allogeneic Cell Therapy Market

12.1. China Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Allogeneic Cell Therapy Market

13.1. India Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Allogeneic Cell Therapy Market

14.1. Japan Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Allogeneic Cell Therapy Market

15.1. Australia Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Allogeneic Cell Therapy Market

16.1. Indonesia Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Allogeneic Cell Therapy Market

17.1. South Korea Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Allogeneic Cell Therapy Market

18.1. Taiwan Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Allogeneic Cell Therapy Market

19.1. South East Asia Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Allogeneic Cell Therapy Market

20.1. Western Europe Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Allogeneic Cell Therapy Market

21.1. UK Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Allogeneic Cell Therapy Market

22.1. Germany Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Allogeneic Cell Therapy Market

23.1. France Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Allogeneic Cell Therapy Market

24.1. Italy Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Allogeneic Cell Therapy Market

25.1. Spain Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Allogeneic Cell Therapy Market

26.1. Eastern Europe Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Allogeneic Cell Therapy Market

27.1. Russia Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Allogeneic Cell Therapy Market

28.1. North America Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Allogeneic Cell Therapy Market

29.1. USA Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Allogeneic Cell Therapy Market

30.1. Canada Allogeneic Cell Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Allogeneic Cell Therapy Market

31.1. South America Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Allogeneic Cell Therapy Market

32.1. Brazil Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Allogeneic Cell Therapy Market

33.1. Middle East Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Allogeneic Cell Therapy Market

34.1. Africa Allogeneic Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Allogeneic Cell Therapy Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Allogeneic Cell Therapy Market Regulatory and Investment Landscape

36. Allogeneic Cell Therapy Market Competitive Landscape And Company Profiles

36.1. Allogeneic Cell Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Allogeneic Cell Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Allogeneic Cell Therapy Market Company Profiles

36.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Poseida Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Allogeneic Cell Therapy Market Other Major And Innovative Companies

Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

38. Global Allogeneic Cell Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Allogeneic Cell Therapy Market

40. Allogeneic Cell Therapy Market High Potential Countries, Segments and Strategies

40.1 Allogeneic Cell Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Allogeneic Cell Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Allogeneic Cell Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Allogeneic Cell Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Allogeneic Cell Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Allogeneic Cell Therapy Market, Supply Chain Analysis
  • Table 4: Global Allogeneic Cell Therapy Market, Major Raw Material Providers
  • Table 5: Global Allogeneic Cell Therapy Market, Major Resource Providers
  • Table 6: Global Allogeneic Cell Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Allogeneic Cell Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Allogeneic Cell Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Allogeneic Cell Therapy Market, Major Trends
  • Table 10: Global Allogeneic Cell Therapy Market, Major End Users
  • Table 11: Global Allogeneic Cell Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Allogeneic Cell Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Allogeneic Cell Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Allogeneic Cell Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Non-Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Allogeneic Cell Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Allogeneic Cell Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Allogeneic Cell Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Allogeneic Cell Therapy Market - Company Scoring Matrix
  • Table 96: Novartis AG Financial Performance
  • Table 97: Bristol Myers Squibb Company Financial Performance
  • Table 98: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 99: Bluebird Bio Inc. Financial Performance
  • Table 100: Poseida Therapeutics Inc. Financial Performance
  • Table 101: Global Allogeneic Cell Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Allogeneic Cell Therapy Market, Competitive Dashboard
  • Table 103: Global Allogeneic Cell Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Table 106: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Allogeneic Cell Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Allogeneic Cell Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Allogeneic Cell Therapy Market, Supply Chain Analysis
  • Figure 4: Global Allogeneic Cell Therapy Market, Major Raw Material Providers
  • Figure 5: Global Allogeneic Cell Therapy Market, Major Resource Providers
  • Figure 6: Global Allogeneic Cell Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Allogeneic Cell Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Allogeneic Cell Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Allogeneic Cell Therapy Market, Major Trends
  • Figure 10: Global Allogeneic Cell Therapy Market, Major End Users
  • Figure 11: Global Allogeneic Cell Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Allogeneic Cell Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Allogeneic Cell Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Allogeneic Cell Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Non-Stem Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Allogeneic Cell Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Allogeneic Cell Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Allogeneic Cell Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Allogeneic Cell Therapy Market - Company Scoring Matrix
  • Figure 96: Novartis AG Financial Performance
  • Figure 97: Bristol Myers Squibb Company Financial Performance
  • Figure 98: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 99: Bluebird Bio Inc. Financial Performance
  • Figure 100: Poseida Therapeutics Inc. Financial Performance
  • Figure 101: Global Allogeneic Cell Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Allogeneic Cell Therapy Market, Competitive Dashboard
  • Figure 103: Global Allogeneic Cell Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Figure 106: Global, Allogeneic Cell Therapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Allogeneic Cell Therapy Market Report 2026 - Global Outlook – By Type (Stem Cell Therapies, Non-Stem Cell Therapies ), By Therapeutic Area (Hematological Disorders, Dermatological Disorders), By End User (Hospitals, Spec...

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Autologous Cell Therapy Market Report 2026 - Global Outlook – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem ...

Allergy Treatment Market Report 2026 - Global Outlook – By Treatment Type (Anti-Allergy Drugs, Immunotherapy), By Type (Eye Allergy, Skin Allergy, Food Allergy, Rhinitis, Other Types), By Route of Administration (Oral, P...

Cell Regeneration Medicine Market Report 2026 - Global Outlook – By Product (Therapeutics, Tools, Banks, Services), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovasc...

Cell And Gene Therapy Clinical Trial Services Market Report 2026 - Global Outlook – By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Bio...

Allergy Immunotherapy Market Report 2026 - Global Outlook – By Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies), By Treatment (Subcutaneous ...

Frequently Asked Questions

The Allogeneic Cell Therapy market was valued at $1.2 billion in 2025, increased to $1.34 billion in 2026, and is projected to reach $1.97 billion by 2030. request a sample here

The global Allogeneic Cell Therapy market is expected to grow at a CAGR of 10.2% from 2026 to 2035 to reach $1.97 billion by 2035. request a sample here

Some Key Players in the Allogeneic Cell Therapy market Include, Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG . request a sample here

Major trend in this market includes: Innovative Cell Processing Platforms Strengthen Market Position Of Allogeneic Cell Therapy Companies. For further insights on this market. request a sample here

North America was the largest region in the allogeneic cell therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Allogeneic Cell Therapy Market Report 2026 market are Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG request a sample here.

North America was the largest region in the allogeneic cell therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us